Only biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetMino-WrapMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearThere are noFDAapproveddrugs to treathemorrhoidsHemorrhoidsis a $2BmarketI'm ashareholdermyselfMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateMino-Lokpotentialmarket>$1BInsidersinvested$26.5mWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever madeOnly biotechwith 2 Myron'son theleadershipteamNot manycompaniesthis size with2 late stageassetsI/ONTAKis our leadassetMino-WrapMyron Holubiakand I founded aprivatecompany in2013The name Citiuscomes from theOlympic motto"Citius,AltiusFortius"We haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityI won't diluteshareholdersWe expect tofinish theMino-Loktrial this yearThere are noFDAapproveddrugs to treathemorrhoidsHemorrhoidsis a $2BmarketI'm ashareholdermyselfMino-Lokis our leadassetI/ONTAK'spotentialmarket is>$300mWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateMino-Lokpotentialmarket>$1BInsidersinvested$26.5mWe had aphase 2btrial with100%efficacyOur Halo-Lido trial willhave finalpatient byend of 2022We intendto submita BLA in2H 2022I/ONTAKwas thebest deal Iever made

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Only biotech with 2 Myron's on the leadership team
  2. Not many companies this size with 2 late stage assets
  3. I/ONTAK is our lead asset
  4. Mino-Wrap
  5. Myron Holubiak and I founded a private company in 2013
  6. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  7. We have enough cash to go well into 2023
  8. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  9. We will have exclusivity
  10. I won't dilute shareholders
  11. We expect to finish the Mino-Lok trial this year
  12. There are no FDA approved drugs to treat hemorrhoids
  13. Hemorrhoids is a $2B market
  14. I'm a shareholder myself
  15. Mino-Lok is our lead asset
  16. I/ONTAK's potential market is >$300m
  17. We will open up international sites for Mino-Lok trial
  18. An actual iMSC update
  19. Mino-Lok potential market >$1B
  20. Insiders invested $26.5m
  21. We had a phase 2b trial with 100% efficacy
  22. Our Halo-Lido trial will have final patient by end of 2022
  23. We intend to submit a BLA in 2H 2022
  24. I/ONTAK was the best deal I ever made